Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
Claudia X. Dominguez, Sören Müller, Shilpa Keerthivasan et al. · Cancer Discovery · 2019
Abstract With only a fraction of patients responding to cancer immunotherapy, a better understanding of the entire tumor microenvironment is needed. Using single-cell transcriptomics, we chart the fibroblastic landscape during pancreatic ductal adenocarcinoma (PDAC) progression in animal models. We identify a population of carcinoma-associated fibroblasts (CAF) that are programmed by TGFβ and express the leucine-rich repeat containing 15 (LRRC15) protein. These LRRC15+ CAFs surround tumor islets and are absent from normal pancreatic tissue. The presence of LRRC15+ CAFs in human patients was confirmed in >80,000 single cells from 22 patients with PDAC as well as by using IHC on samples from 70 patients. Furthermore, immunotherapy clinical trials comprising more than 600 patients across six cancer types revealed elevated levels of the LRRC15+ CAF signature correlated with poor response to anti–PD-L1 therapy. This work has important implications for targeting nonimmune elements of the tumor microenvironment to boost responses of patients with cancer to immune checkpoint blockade therapy. Significance: This study describes the single-cell landscape of CAFs in pancreatic cancer during in vivo tumor evolution. A TGFβ-driven, LRRC15+ CAF lineage is associated with poor outcome in immunotherapy trial data comprising multiple solid-tumor entities and represents a target for combinatorial therapy. This article is highlighted in the In This Issue feature, p. 161
Cited by 851 works. doi:10.1158/2159-8290.cd-19-0644
Authors
- Claudia X. Dominguez
- Sören Müller
- Shilpa Keerthivasan
- Hartmut Koeppen
- Jeffrey Hung
- Sarah Gierke
- Béatrice Bréart
- Oded Foreman
- Travis W. Bainbridge
- Alessandra Castiglioni
- Yasin Şenbabaoğlu
- Zora D. Modrusan
- Yuxin Liang
- Melissa R. Junttila
- Christiaan N. Klijn
- Richard Bourgon
- Shannon J. Turley
References
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- Integrative genomics viewer
- Comprehensive Integration of Single-Cell Data
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- Fast, sensitive and accurate integration of single-cell data with Harmony
- The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists
- The Immune Landscape of Cancer
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells